Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Total Current Liabilities (2021 - 2025)

Lucid Diagnostics' Total Current Liabilities history spans 5 years, with the latest figure at $28.6 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 21.5% year-over-year to $28.6 million; the TTM value through Dec 2025 reached $28.6 million, up 21.5%, while the annual FY2025 figure was $28.6 million, 21.5% up from the prior year.
  • Total Current Liabilities reached $28.6 million in Q4 2025 per LUCD's latest filing, up from $26.2 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $36.6 million in Q1 2025 to a low of $4.3 million in Q4 2021.
  • Average Total Current Liabilities over 5 years is $20.5 million, with a median of $23.4 million recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 248.75% in 2023, then crashed 52.86% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $4.3 million in 2021, then skyrocketed by 97.77% to $8.4 million in 2022, then surged by 248.75% to $29.4 million in 2023, then decreased by 19.94% to $23.5 million in 2024, then increased by 21.5% to $28.6 million in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Total Current Liabilities are $28.6 million (Q4 2025), $26.2 million (Q3 2025), and $29.4 million (Q2 2025).